NCT02755116View on ClinicalTrials.gov

Olanzapine for Nausea After Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 5, 2019

Study Completion Date

September 5, 2019

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Olanzapine

10mg of olanzapine by mouth prior to anesthetic induction

DRUG

Placebo

placebo by mouth prior to anesthetic induction

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Jaime B Hyman

OTHER

NCT02755116 - Olanzapine for Nausea After Surgery | Biotech Hunter | Biotech Hunter